Reference Prices and Generic Medicines: What Can We Expect?
暂无分享,去创建一个
[1] M. Gemmill,et al. Pharmaceutical pricing and reimbursement in Europe , 2005 .
[2] Jaume Puig-Junoy,et al. Incentives and pharmaceutical reimbursement reforms in Spain. , 2004, Health policy.
[3] Panos Kanavos,et al. Reference pricing for drugs: is it compatible with U.S. health care? , 2003, Health affairs.
[4] J. McNeil,et al. Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes. , 2002, PharmacoEconomics.
[5] J. Mestre-Ferrandiz. REFERENCE PRICES: THE SPANISH WAY , 2000 .
[6] J. Puig-Junoy,et al. Review of the literature on reference pricing. , 2000, Health policy.
[7] Nina Pavcnik,et al. Do Pharmaceutical Prices Respond to Insurance? , 2000 .
[8] J. M. Ferrándis. Relación entre un Sistema de Precios de Referencia y Medicamentos Genéricos , 1999 .
[9] M. Drummond,et al. The role of economic evaluation in the pricing and reimbursement of medicines. , 1997, Health policy.